These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9795924

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group.
    Saracco G, Ciancio A, Ghisetti V, Rocca G, Cariti G, Andreoni M, Tabone M, Roffi L, Calleri G, Ballaré M, Terreni N, Sartori M, Tappero GF, Traverso A, Poggio A, Orani A, Maggi G, Di Napoli A, Arrigoni A, Rizzetto M, North West Italian Hepatological Group.
    Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):149-55. PubMed ID: 11246614
    [Abstract] [Full Text] [Related]

  • 63. Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients.
    Brouwer JT, Nevens F, Kleter B, Elewaut A, Adler M, Brenard R, Chamuleau RA, Michielsen PP, Pirotte J, Hautekeete ML, Weber J, Bourgeois N, Hansen BE, Bronkhorst CM, ten Kate FJ, Heijtink RA, Fevery J, Schalm SW.
    J Hepatol; 1998 Jun; 28(6):951-9. PubMed ID: 9672169
    [Abstract] [Full Text] [Related]

  • 64. Utility of hepatitis C virus serotypes in predicting response to treatment of chronic hepatitis C. Consensus Interferon Study Group.
    Keeffe EB, Dusheiko GM, James SP, Mullen KD, Everson GT, Pimstone NR, Donovan J, Albert D.
    Cytokines Cell Mol Ther; 1999 Dec; 5(4):207-10. PubMed ID: 10850384
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy.
    Bekkering FC, Brouwer JT, Leroux-Roels G, Van Vlierberghe H, Elewaut A, Schalm SW.
    J Hepatol; 1998 Jun; 28(6):960-4. PubMed ID: 9672170
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C.
    Garson JA, Brillanti S, Whitby K, Foli M, Deaville R, Masci C, Miglioli M, Barbara L.
    J Med Virol; 1995 Mar; 45(3):348-53. PubMed ID: 7775960
    [Abstract] [Full Text] [Related]

  • 69. A randomized, double-blind, controlled trial of consensus interferon in the treatment of Chinese patients with chronic hepatitis C.
    Hwang SJ, Lee SD, Chan CY, Lu RH, Chang FY.
    Am J Gastroenterol; 1999 Sep; 94(9):2496-500. PubMed ID: 10484014
    [Abstract] [Full Text] [Related]

  • 70. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
    Gallegos-Orozco JF, Fuentes AP, Olivera-Martinez MA, Gutiérrez-Reyes G, Cortina D, Oregel JA, Pérez-Pruna C, Sixtos MS, Cruz-Castellanos S, Soto-Ramírez LE, Rodríguez-Díaz R, Fuentes-Romero L, Gutiérrez-Ruiz MC, Kershenobich D.
    Rev Invest Clin; 2003 Sep; 55(2):138-42. PubMed ID: 12827916
    [Abstract] [Full Text] [Related]

  • 71. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC, Bacon BR, Goldin RD.
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [Abstract] [Full Text] [Related]

  • 72. Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.
    Crespo M, Mira JA, Pineda JA, Van den Eynde E, Ríos-Villegas MJ, Collado A, Girón-González JA, López-Cortés LF, González-Serrano M, Rivero A, Merino D, Esteban JI.
    J Antimicrob Chemother; 2008 Oct; 62(4):793-6. PubMed ID: 18567911
    [Abstract] [Full Text] [Related]

  • 73. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O, Chen M, Lindh G, Mattsson L, Schvarcz R, Sönnerborg A, Wahl M, Wejstål R, Widell A, Norkrans G.
    Scand J Infect Dis; 1995 Oct; 27(5):319-24. PubMed ID: 8588128
    [Abstract] [Full Text] [Related]

  • 74. The sustained virologic response of nonresponder hepatitis C virus patients with retreatment.
    Akhan SC, Gurel E, Sayan M.
    Indian J Pathol Microbiol; 2011 Oct; 54(1):81-4. PubMed ID: 21393883
    [Abstract] [Full Text] [Related]

  • 75. Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group.
    Reichard O, Norkrans G, Frydén A, Braconier JH, Sönnerborg A, Weiland O.
    Lancet; 1998 Jan 10; 351(9096):83-7. PubMed ID: 9439491
    [Abstract] [Full Text] [Related]

  • 76. The role of alpha-glutathione S-transferase in the monitoring of hemodialysis patients with hepatitis C virus infection undergoing high-dose interferon-alpha-2b therapy.
    Boran M, Cetin S.
    Nephron; 1999 Jan 10; 82(1):22-6. PubMed ID: 10224480
    [Abstract] [Full Text] [Related]

  • 77. A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone.
    Fattovich G, Zagni I, Ribero ML, Castagnetti E, Minola E, Lomonaco L, Scattolini C, Fabris P, Boccia S, Giusti M, Abbati G, Felder M, Rovere P, Redaelli A, Tonon A, Tomba A, Montanari R, Paternoster C, Distasi M, Fornaciari G, Tositti G, Rizzo C, Suppressa S, Pantalena M, Noventa F, Tagger A.
    J Viral Hepat; 2004 Nov 10; 11(6):543-51. PubMed ID: 15500555
    [Abstract] [Full Text] [Related]

  • 78. Re-treatment of patients with hepatitis C who failed to respond (nonresponders) to previous treatment.
    Sharvadze LG, Gogichaishvili ShSh, Sakandelidze TsG, Zhamutashvili MT, Chkhartishvili NI.
    Georgian Med News; 2009 Jan 10; (166):61-4. PubMed ID: 19202222
    [Abstract] [Full Text] [Related]

  • 79. Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection.
    Urushihara A, Sodeyama T, Matsumoto A, Tanaka E.
    J Med Virol; 1994 Apr 10; 42(4):348-56. PubMed ID: 7519250
    [Abstract] [Full Text] [Related]

  • 80. Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis.
    Derbala M, Amer A, Bener A, Lopez AC, Omar M, El Ghannam M.
    J Viral Hepat; 2005 Jul 10; 12(4):380-5. PubMed ID: 15985008
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.